UBS Group’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-288
Closed -$118K 11003
2022
Q1
$118K Buy
+288
New +$106K ﹤0.01% 5781
2021
Q4
Sell
-313
Closed -$139K 10756
2021
Q3
$139K Hold
313
﹤0.01% 5597
2021
Q2
$147K Buy
+313
New +$187K ﹤0.01% 5591
2020
Q1
Sell
-261
Closed -$253K 8460
2019
Q4
$253K Buy
261
+106
+68% +$128K ﹤0.01% 5431
2019
Q3
$235K Buy
+155
New +$247K ﹤0.01% 5120
2018
Q4
Sell
-2
Closed -$3K 8331
2018
Q3
$3K Buy
+2
New +$3.85K ﹤0.01% 7670

Other funds holding VXX

UBS Group's VXX Position: Q1 2026 in Review

UBS Group reduced its iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) stake by 81% in Q1 2026, selling an estimated $16.9M and leaving 135,228 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4111.

UBS Group first reported a position in VXX in Q1 2018 and has held it in 31 quarters since. The position peaked at $18.6M in Q4 2025. 76 funds tracked by Wall St. Rank hold VXX as of Q1 2026.

  • UBS Group held 135,228 shares of iPath Series B S&P 500 VIX Short-Term Futures ETN worth $4.83M as of Q1 2026.
  • UBS Group sold 569,057 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q1 2026, an estimated $16.9M.
  • iPath Series B S&P 500 VIX Short-Term Futures ETN made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4111 holding.
  • UBS Group first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q1 2018 and has held it in 31 quarters since.
  • UBS Group's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $18.6M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.